| Literature DB >> 22606228 |
Christopher J Hyatt1, Michal Assaf, Christine E Muska, Rivkah I Rosen, Andre D Thomas, Matthew R Johnson, Jennifer L Hylton, Melissa M Andrews, Brady A Reynolds, John H Krystal, Marc N Potenza, Godfrey D Pearlson.
Abstract
Cocaine addiction is characterized by impulsivity, impaired social relationships, and abnormal mesocorticolimbic reward processing, but their interrelationships relative to stages of cocaine addiction are unclear. We assessed blood-oxygenation-level dependent (BOLD) signal in ventral and dorsal striatum during functional magnetic resonance imaging (fMRI) in current (CCD; n = 30) and former (FCD; n = 28) cocaine dependent subjects as well as healthy control (HC; n = 31) subjects while playing an interactive competitive Domino game involving risk-taking and reward/punishment processing. Out-of-scanner impulsivity-related measures were also collected. Although both FCD and CCD subjects scored significantly higher on impulsivity-related measures than did HC subjects, only FCD subjects had differences in striatal activation, specifically showing hypoactivation during their response to gains versus losses in right dorsal caudate, a brain region linked to habituation, cocaine craving and addiction maintenance. Right caudate activity in FCD subjects also correlated negatively with impulsivity-related measures of self-reported compulsivity and sensitivity to reward. These findings suggest that remitted cocaine dependence is associated with striatal dysfunction during social reward processing in a manner linked to compulsivity and reward sensitivity measures. Future research should investigate the extent to which such differences might reflect underlying vulnerabilities linked to cocaine-using propensities (e.g., relapses).Entities:
Mesh:
Year: 2012 PMID: 22606228 PMCID: PMC3351439 DOI: 10.1371/journal.pone.0034917
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographics, Drug Usage and Axis-I SCID data for HC, FCD and CCD groups.
| Demographics | CCD (n = 30) | FCD (n = 28) | HC (n = 31) | ANOVA test | p-val | ||||||
| Mean | SD | Range | Mean | SD | Range | Mean | SD | Range | |||
| Age | 37.9 | 8.1 | 22–55 | 37.9 | 8.1 | 21–50 | 35.6 | 7.4 | 25–59 |
|
|
| IQ | 97.7 | 13.3 | 74–123 | 99.9 | 16.2 | 77–141 | 107.4 | 17.8 | 74–141 |
| 0.059 |
| Gender (% M/F) | 63.3/36.7 | 64.3/35.7 | 71.0/29.0 | χ2(2) = 0.471 |
| ||||||
| Ethnicity (% W/B/H/A) | 53.3/30.0/13.3/3.3 | 60.7/28.6/7.1/3.6 | 77.4/9.7/9.7/3.2 | χ2(6) = 7.227 |
| ||||||
|
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
|
| |||
| Age at first use (years) | 20.5 | 6.3 | 13–42 |
|
|
| |||||
| Duration of use (years) | 16.5 | 8.1 | 1.5–30 | 11.1 | 9.0 | 0.3–29 |
|
| 0.021 | ||
| Amount used (weekly, USD) | $253 | $317 | $20–$1,400 | $741 | $911 | $16–$2,632 |
|
| 0.011 | ||
| Abstinence duration (years) |
| 4.6 | 6.5 | 0.5–20 |
|
| |||||
| Urine Test (pos/neg) | 20/10 | 0/28 | 0/31 |
| |||||||
|
|
|
|
| ||||||||
|
|
|
|
|
|
| ||||||
| Cocaine | 27/3 | N/A | 0/0 | 25/3 | 0 | 0 | |||||
| Alcohol | 4/0 | 13/6 | 0/1 | 16/3 | 0 | 0 | |||||
| Cannabis | 4/3 | 10/6 | 1/1 | 10/2 | 0 | 0 | |||||
| Opiate | 9/0 | 1/1 | 0/0 | 7/1 | 0 | 0 | |||||
| Amphetamine/Stimulant | 0/0 | 0/1 | 0/0 | 2/1 | 0 | 0 | |||||
| Hallucinogen/PCP | 0/0 | 2/3 | 0/0 | 1/1 | 0 | 0 | |||||
| Sedative/Anxiolytic | 0/0 | 2/4 | 0/0 | 1/2 | 0 | 0 | |||||
| Nicotine (daily smoker) | 24 | 2 | 19 | 3 | 2 | 3 | |||||
|
|
|
|
|
|
|
| |||||
| Major Depression | 0 | 2 | 0 | 1 | 0 | 0 | |||||
| Specific Phobia | 1 | 0 | 1 | 0 | 0 | 0 | |||||
| Panic Disorder | 1 | 0 | 0 | 0 | 0 | 0 | |||||
| Mood Disorder (SI) | 0 | 2 | 0 | 5 | 0 | 0 | |||||
| PTSD | 0 | 1 | 0 | 4 | 0 | 0 | |||||
| Dysthymic Disorder | 0 | 0 | 1 | 0 | 0 | 0 | |||||
| Bipolar I Disorder | 0 | 0 | 0 | 1 | 0 | 0 | |||||
The DSM-IV diagnosis for current or past drug dependence or abuse is demarcated by a forward slash (e.g., 27/3 indicates 27 diagnosed with dependence and 3 with abuse of the given drug).
A, Asian; B, Black; F, female; H, Hispanic; M, male; N/A, not applicable; ns, non-significant; SD, standard deviation; W, white.
Day of scan only; 2two-sample t-test CCD versus FCD only.
C, Current; P, Past; USD, United States dollars; N/A, not applicable; PCP, phencyclidine; PTSD, post traumatic stress disorder; SI, substance induced.
Figure 1The Domino game task. The Domino game sequence and corresponding consequences are depicted.
At the beginning of each round of the game the player must decide (mentally choose) what chip he/she will play next (i.e., ‘Choose’, the decision-making interval) and move the cursor to the selected chip when instructed (‘Ready’ interval). The chip can either match the opponent’s chip (i.e., have one of the two numbers on the chip match one of those on the opponent’s chip, 6∶3 in this example; upper panel, 6∶1) or not (lower panel, 5∶2). After placing the selected chip face down next to the opponent’s chip, he/she awaits the opponent’s response (‘Go’ or ‘Anticipation of Outcome’ interval). The opponent can either challenge the player’s choice (‘show’) or not (‘no-show’). Based on the player’s choice and the opponent’s response, there are four possible consequences for each round during the ‘Response to Outcome’ interval: show match (overt gain); no-show match (relative loss, as the player could have been rewarded if challenged); show non-match (overt loss) and no-show non-match (relative gain, as the player successfully “bluffed”, that is, avoided punishment). The opponent’s chip and samples of matching and non-matching chips are highlighted (in yellow) for demonstration purposes only. In the actual scan, the game board and all chips are in color, not in grayscale as depicted in the figure. Also, all chips are the same size and color.
Statistical group comparisons for responses to four attitude statements (AS).
| AS1: | I felt glad when a matching chip was challenged (show match: | |||||||||
| AS2: | I felt glad when a non-matching was not challenged (no-show non-match: | |||||||||
| AS3: | I felt unhappy when a non-matching chip was challenged (show non-match: | |||||||||
| AS4: | I felt unhappy when a matching chip was not challenged (no-show match: | |||||||||
|
| ||||||||||
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
| |||
|
| 3.97±1.02 | <0.001 | 3.83±1.00 | <0.001 | 3.07±1.10 | = 0.369 | 2.93±1.33 | = 0.391 | ||
|
| 4.00±1.05 | <0.001 | 3.79±1.23 | <0.001 | 3.22±1.28 | = 0.188 | 3.29±1.27 | = 0.123 | ||
|
| 4.21±1.07 | <0.001 | 3.92±1.38 | <0.001 | 3.39±1.45 | = 0.081 | 3.18±1.42 | = 0.255 | ||
|
| ||||||||||
|
|
|
|
| |||||||
| χ2 | 1.665 | 0.874 | 1.157 | 0.955 | ||||||
|
| 0.435 | 0.646 | 0.561 | 0.620 | ||||||
From the Domino Debriefing Questionnaire (DDQ) regarding absolute and relative gains and losses during the ‘Response to Outcome’ interval. Responses are Likert scale for agreement with each statement: 1 = ’Not at all’ through 5 = ’Very much’. Top, Table values are the response mean and standard deviation for each group. Bottom, Kruskal-Wallis test results for group differences.
= Null hypothesis, mean response ≤3.
Figure 2Statistical parametric one-sample t-maps of the Gain-Loss contrast for all groups combined (n = 89 subjects) that delineates the “Reward network”.
Axial slices are labeled from z = −18 mm to z = +3 mm in steps of 3 mm. The threshold was set at p<0.05, FWE whole-brain corrected.
Statistical parametric mapping results for the Gain-Loss contrast.
| One-sample | |||||
| Anatomic location of maximum activation | MNI coordinates |
| |||
| x | y | Z |
| ||
| L ventral striatum | −15 | 9 | −9 | 9.32 | |
| R ventral striatum | 12 | 12 | −6 | 9.20 | |
| L OFC | −39 | 51 | −9 | 7.46 | |
| R OFC | 33 | 60 | −3 | 7.34 | |
| L sup parietal lobe | −42 | −36 | 39 | 6.86 | |
| R sup parietal lobe | 39 | −36 | 39 | 6.54 | |
| Threshold: | |||||
| OFC, orbitofrontal cortex; sup, superior | |||||
|
| |||||
|
|
|
| |||
| x | y | Z |
|
| |
| R dorsal caudate | 18 | 18 | 9 | 5.16 | 0.0076 |
| Threshold: | |||||
Across all groups one-sample t-test (top) and for the between-group ANOVA main effect, masked with the Reward mask (bottom).
Figure 3A. Statistical parametric F-maps (sagittal, coronal and axial) of the Gain-Loss contrast for one-way ANOVA between-group main effect (masked with the Reward mask).
Crosshairs overlaid on brain slices are at located at x,y,z = 18,18,9 (peak voxel). Glass brain at top right shows that the cluster in the right dorsal caudate is only surviving cluster. Threshold was set at p<0.05 uncorrected, minimum cluster size k = 10 voxels. B. Effect sizes for Gain (red), Loss (blue) and Gain-Loss (green) contrasts for HC, FCD and CCD groups at x,y,z = 18,18,9. Black bar represents standard error of the mean.
Between-group ANOVA multiple regression results: Gain-Loss contrast versus impulsivity-related Factor 2 scores.
| Anatomic location of maximum between-group difference in correlation | MNI coordinates | Factor 2 vs | |||
| x | y | z |
|
| |
|
| |||||
| R dorsal caudate | 15 | 18 | 0 | 5.27 | 0.007 |
|
| |||||
| R OFC | 21 | 33 | −9 | 7.96 | 0.001 |
| L IFG, triangular | −51 | 39 | 6 | 7.10 | 0.001 |
| R IFG, opercular | 57 | 9 | 27 | 5.00 | 0.009 |
| L middle frontal gyrus | −36 | 60 | 9 | 4.59 | 0.013 |
| L precentral gyrus | −51 | 3 | 24 | 5.54 | 0.006 |
| L precentral gyrus | −42 | −3 | 57 | 4.69 | 0.012 |
| L superior parietal lobe | −27 | −57 | 66 | 7.82 | 0.001 |
| R precuneus | 6 | −66 | 45 | 5.17 | 0.008 |
Threshold: p<0.05 uncorrected, minimum cluster size, k = 10 voxels; masked with Reward mask.
IFG, inferior frontal gyrus.
Figure 4A. Statistical parametric F-maps (coronal slices; y-dimension shown) of the one-way between-groups ANOVA multiple regression analysis of Factor 2 scores versus Gain-Loss contrast.
Block white arrow points to the right dorsal caudate cluster that overlaps with the right dorsal caudate cluster shown in Figure 4, panel A. B. Statistical parametric t-maps (coronal slices; y-dimension shown) for the post hoc FCD group multiple regression analysis of Factor 2 scores versus Gain-Loss contrast. Threshold was set at q<0.05 FDR corrected; minimum cluster size k = 10 voxels (masked with the Reward mask). C. Plot of the Gain-Loss effect size versus Factor 2 score regression analysis, with each Gain-Loss contrast value being the mean value in a 5 mm radius sphere centered at peak voxel x,y,z = 18,18,0 for each subject in the FCD group. The correlation coefficient of the fitted line was R = −0.641 (p = 0.0002 uncorrected).
FCD group post-hoc multiple regression results for Gain-Loss contrast versus impulsivity Factor 2 scores.
| Anatomic location of maximum correlation | MNI coordinates | Factor 2 vs | ||||
| x | y | z |
|
|
| |
|
| ||||||
| R dorsal caudate | 18 | 18 | 0 | 4.29 | 0.0002 | −0.644 |
| L ventral striatum | −15 | 12 | −6 | 3.89 | 0.0006 | −0.607 |
| R ventral striatum | 15 | 12 | −3 | 3.39 | 0.0022 | −0.554 |
|
| ||||||
| R IFG, opercular | 54 | 9 | 24 | 3.84 | 0.0007 | −0.602 |
| L superior parietal lobe | −24 | −57 | 63 | 5.18 | <0.0001 | −0.712 |
| L precentral gyrus | −33 | −3 | 63 | 4.03 | 0.0004 | −0.620 |
| R precuneus | 12 | −72 | 57 | 3.57 | 0.0014 | −0.574 |
| R precentral gyrus | 36 | −9 | 66 | 4.24 | 0.0002 | −0.639 |
Threshold: q<0.05 FDR correction, minimum cluster size, k = 10 voxels; masked with Reward mask.